First US Lucentis Biosimilar Expected By Year End, Roche Confirms

Samsung Bioepis’ SB11 Biosimilar Pending With FDA

 
• By Dean Rudge
  
Female eye with long eyelashes close up. Closeup shot of female gray - blue colour eye with day makeup. Beauty female eye with curl long eyelashes
Samsung Bioepis' SB11 candidate is pending approval with the USFDA • Source: Shutterstock

More from Biosimilars

More from Products